Industry reports
Editor highlights

Publication dates

Antibody Research Reports, April 2014

You might be interested in: flow cytometry, diagnostic, disease testing, more »


 

1-10 of about 200 reports for Antibody
Automated Blood Grouping & Antibody Test Systems - Medical Device Safety and Approval Report - Comprehensive

Automated Blood Grouping & Antibody Test Systems - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • April 2014
  • by DeviceMatters

... Automated blood grouping & antibody test systems - medical device safety and approval report - comprehensive the comprehensive devicematters medical device safety and approval report provides ...

Hepatitis A Tests (Antibody & IGM Antibody) - Medical Device Safety and Approval Report - Comprehensive

Hepatitis A Tests (Antibody & IGM Antibody) - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • April 2014
  • by DeviceMatters

... Hepatitis a tests (antibody & igm antibody) - medical device safety and approval report - comprehensive the comprehensive devicematters medical device safety and approval report provides an overview ...

Physician Views - Are physicians getting the biosimilar education they need?

Physician Views - Are physicians getting the biosimilar education they need?

  • $ 731
  • Industry report
  • April 2014
  • by Firstword Pharma

... Of the first biosimilar antibodies, however, there has been a steady shift in focus from the development/regulatory space to the commercial landscape. Many questions are being asked; how will biosimilars compete ...

Antibodies in Oncology: Drug Pathway Analyzer 2014

Antibodies in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the antibody ...

Antibodies in Oncology Drug Pipeline Update 2014

Antibodies in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... antibodies in oncology drug pipeline update 2014 the commercial and therapeutic success of antibodies like rituxan, avastin, and erbitux will force the industry to look into the next generation ...

Analytical Tool - Cancer Therapeutic Antibodies

Analytical Tool - Cancer Therapeutic Antibodies

  • $ 5 924
  • Industry report
  • March 2014
  • by Bioseeker

... Reflects the most recent advances in the field of antibody drug development in cancer, in order to help you perform your own analysis, go back to the source data for in-depth information, and present ...

Competitor Analysis: Cancer Vaccines

Competitor Analysis: Cancer Vaccines

  • $ 1 056
  • Industry report
  • March 2014
  • by La Merie Publishing

... Antigenic constituents: peptides, recombinant proteins, idiotype antibody, dna (plasmid, expression vector), rna, virus-like particles (vlp), dendritic cells, tumor cells (tumor cell lines), microorganism ...

Ablynx NV (Symbol:ABLX) SWOT Analysis, Strategy, Revenues and Profits

Ablynx NV (Symbol:ABLX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2014
  • by Global Data

... Class of antibody-derived therapeutic proteins based on antibody fragments consisting of a single monomeric variable antibody domain. It has advantages of conventional antibodies along with the key ...

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014

  • $ 1 452
  • Industry report
  • March 2014
  • by La Merie Publishing

... Biosimilar and biosuperior therapeutic antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products ...

Genovis AB (GENO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genovis AB (GENO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

... The company provides, fabricator, a specific proteolytic enzyme which cleaves all human, rabbit, monkey and sheep igg subclasses. In antibody deglycosylation segment the company provides, ig ...


» Read our Company Profiles

5 Companies for Antibody

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Abbott Laboratories

United States

Merck KGaA

Germany

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.